IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: El Eit et al.'s experimental studies on CML mouse models concluded that IFN may allow TML-resistant CML mice to overcome various TKI-specific resistance mechanisms and achieve durable remission [35].